ChromaCode
PrivateLast Round
Series A
Extension
Jan 30, 2025
Total Funding Raised
$66.55M
Company Overview
ChromaCode is a molecular diagnostics company that develops a genomics multiplexing platform utilizing High-Definition PCR technology to enable rapid, accurate, and cost-effective molecular diagnostics testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ChromaCode Comparables
Compare ChromaCode with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aplex Bio | 74% | |
| Signal Bioscience | 71% | |
| Thermo Fisher Scientific Inc. | 71% | |
ChromaCode Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 30, 2025 | ||||
| Strategic | Jun 7, 2023 | ||||
| Grant | Mar 16, 2021 | ||||
| Series C Extension | May 19, 2020 | ||||
| Series C | Dec 17, 2019 | ||||
Series B | Apr 27, 2017 |
Key People
Founding team and executive leadership
ChromaCode Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Okapi Venture Capital | Series B, Series C Extension, Series A, Series C |
| New Enterprise Associates (NEA) | Series C Extension, Series C, Series B |
| Domain Associates | Series B, Series C Extension, Series C, Series A |
| Moore Venture Partners | Series C Extension, Series C |
| Global Brain Corporation | Strategic |
| California Institute of Technology Investment Office | Series C Extension, Series C |
| Northpond Ventures | Series C Extension, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 16, 2021
$500K grant received from XPRIZE Foundation.
- Dec 17, 2019
$38M round led by Adjuvant Capital and Northpond Ventures.
ChromaCode Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ChromaCode's valuation, stock price, and market status.